Transcription of GERD: 증상, 진단 그리고 치료의 최신지견
1 55 303 gerd : , gerd : Symptoms, Diagnosis and Recent Advances in TreatmentJi Yong AhnDepartment of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, KoreaG-I. Room G (gastroesophageal reflux disease, gerd ) , (heartburn) . 10-23% , 25% , 15% , 8% , 9%, 4%.
2 , , , , , . , , . 1. , . , . , , , , . , , , , .2.
3 1) , . , 50% .2) 24 pH pH 24 , , . , gerd : , 304 Korean Society of Gastrointestinal Endoscopy , pH 48 pH .3.
4 , , , ..1) , , , , . , , . , , .2) , . , (H2 blocker) (proton pump inhibitor, PPI).
5 , 4 , 8 . , , , . , .3) , .. , . , (stretta).
6 , , . 1. Chiba N, De Gara CJ, Wilkinson JM, Hunt RH. Speed of heal-ing and symptom relief in grade II to IV gastroesophageal re-flux disease: a meta-analysis. Gastroenterology 1997;112: 1798-1810. 2. Cho YS, Choi MG, Jeong JJ, et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Asan-si, Korea. Am J Gastroenterol 2005;100:747- 753. 3. Eslick GD, Talley NJ. Gastroesophageal reflux disease ( gerd ): risk factors, and impact on quality of life-a pop-ulation-based study.
7 J Clin Gastroenterol 2009;43:111-117. 4. Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol 2013;108:308-328; quiz 329. 5. Khan M, Santana J, Donnellan C, Preston C, Moayyedi P. Medical treatments in the short term management of reflux oesophagitis. Cochrane Database Syst Rev 2007: CD003244. 6. Kim N, Lee SW, Cho SI, et al. The prevalence of and risk fac-tors for erosive oesophagitis and non-erosive reflux disease: a nationwide multicentre prospective study in Korea. Aliment Pharmacol Ther 2008;27:173-185. Epub 2007 Oct 25.
8 7. Moore M, Afaneh C, Benhuri D, Antonacci C, Abelson J, Zarnegar R. Gastroesophageal reflux disease: A review of surgical decision making. World J Gastrointest Surg 2016;8: 77-83.
